Veno-venous extracorporeal membrane oxygenation as a bridge in central airway obstruction: experience from a high-volume center

Crit Care. 2024 Dec 20;28(1):426. doi: 10.1186/s13054-024-05219-0.

Abstract

Background: Perioperative airway management and oxygenation maintenance during central airway obstruction (CAO) treatment pose great challenges. While veno-venous extracorporeal membrane oxygenation (V-V ECMO) shows promise as a bridge therapy, optimal implementation and management strategies remain lacking. We present our experience with V-V ECMO in CAO management from a high-volume center.

Methods: We retrospectively analyzed 29 consecutive patients who received V-V ECMO support for CAO between 2015 and 2023. Patient demographics, clinical characteristics, ECMO cannulation and operation parameters, interventional procedures, complications, and outcomes were reviewed.

Results: Among patients with median airway diameter of 4.5 mm (IQR 2-5 mm), etiologies included primary tumors (n = 17), metastases (n = 7), and post-intubation/tracheostomy stenosis (n = 5). Treatment comprised bronchoscopic interventions (n = 9) and surgical procedures (thoracic = 15, head/neck = 5). Using predominantly femoral-jugular cannulation (n = 27), we implemented a minimal anticoagulation protocol (catheter flush with 5U/mL heparin only). All patients survived through 6-month follow-up with minimal ECMO-related complications.

Conclusion: The application of V-V ECMO with minimal anticoagulation demonstrates safety and efficacy as a bridging support in the therapeutic approach to CAO.

Keywords: Cannulation strategy; Central airway obstruction; ECMO; Minimal anticoagulation protocol.

MeSH terms

  • Adult
  • Aged
  • Airway Obstruction* / etiology
  • Airway Obstruction* / therapy
  • Extracorporeal Membrane Oxygenation* / methods
  • Female
  • Hospitals, High-Volume / statistics & numerical data
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies